04.22.19

Akorn Receives FDA Approval for Generic Loteprednol Etabonate

Source: Akorn

04.02.19

Bausch + Lomb Announces US Launch of Lotemax SM

Source: Bausch + Lomb

03.14.19

Clinical Trials Show Safety and Efficacy of Inveltys for BID Treatment of Postoperative Inflammation and Pain

Source: Kala Pharmaceuticals

02.25.19

FDA Approves Bausch + Lomb’s Lotemax SM For The Treatment Of Postoperative Inflammation And Pain

Source: Bausch + Lomb

09.05.18

Phase 3 Trial of Bausch + Lomb’s Loteprednol Etabonate Drug Candidate Meets Primary Efficacy Endpoints

Source: Bausch Health Companies

08.23.18

Kala Pharmaceuticals Announces FDA Approval of Inveltys for the Treatment of Postoperative Inflammation and Pain

Source: Kala Pharmaceuticals

07.09.18

Bausch + Lomb Announces FDA Filing Acceptance for Loteprednol Etabonate Ophthalmic Gel

Source: Bausch + Lomb

View more stories